Vascon Engineers Share Price Gains Over 4% on Securing Work Order Worth ₹260.09 Crore

On December 15, 2025, Vascon Engineers Limited announced the acquisition of a significant work order from the Navi Mumbai Municipal Corporation.  

The contract involves the construction of a Super Specialty Hospital at Plot No. 4, Sec15A, C.B.D Belapur, Navi Mumbai, on an EPC basis. 

Details of the Work Order 

The work order, valued at ₹260.09 crore, includes GST and outlines the construction of a state-of-the-art Super Specialty Hospital.  

The project is expected to be completed within a 36-month timeframe from the date of the work order issuance. This development is a testament to Vascon Engineers' capabilities in handling large-scale infrastructure projects. 

Significance of the Project 

The Navi Mumbai Municipal Corporation has entrusted Vascon Engineers with this critical project, reflecting the company's strong reputation in the construction industry.  

The hospital will be located in the strategic area of C.B.D Belapur, enhancing healthcare facilities in the region. 

Read More: NBCC Share Price Surges on Securing ₹289.39 Crore Projects from NALCO and SAIL! 

Contractual Terms and Conditions 

The contract specifies that the construction will be executed on an EPC basis, ensuring a streamlined process from design to completion. This approach is expected to facilitate efficient project management and timely delivery. The project is purely domestic, with no involvement from international entities. 

Vascon Engineers Share Price Performance  

As of December 15, 2025, at 1:21 PM, Vascon Engineers share price on NSE was trading at ₹47.29 up by 4.25% from the previous closing price. 

Conclusion 

Vascon Engineers' new contract for constructing a Super Specialty Hospital in Navi Mumbai marks a significant milestone for the company. With a project value of ₹260.09 crore and a completion timeline of 36 months, this development underscores the company's expertise in executing large-scale infrastructure projects. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.